(Date:11/5/2009)...ITHERSBURG, Md., Nov. 5 ...financial results for the third quarter ended Sept... million ($0.04 per share) for the three months en...6.8 million ($0.08 per share) in the comparable qu... 30, 2009, GenVec,s net loss was $14.1 million ($0...
(Date:11/5/2009)...N DIEGO, Nov. 5 Imagenet...ay that William Spencer, President and CEO of Imag...the 2nd annual LD MICRO Conference on Thursday, De...Los Angeles. ,, About LD MICRO ,, LD MICRO i...s on finding undervalued companies in the micro-ca...
(Date:11/5/2009)...AHA, Neb., Nov. 5 Transg...unced financial results for the quarter ended Sept...e presented in the tables that follow. ,, Thir...oss of $366,000 or $0.01 per share for the third q...00 or $0.01 per share for the third quarter of 200...
(Date:11/5/2009)...RT WORTH, Texas, Nov. 5 ...nced today that it has entered into a Letter of In...Virtual Health Technologies, Inc. (OTC Bulletin Bo...$1,000,000 in cash and debt, 4,000,000 shares of W... by WNDM on the Veriscrip technology being acquire...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3...New Flavor Ingredient Achieves ...ber 28, 2008 Senomyx,Inc. (Nasdaq: SNMX ), a lea...gies to discover and develop novel flavor ingredie...dustries, announced today that it has,received a p...ated to a,milestone achieved by Senomyx under the ...
...n Company,s Website -, TUSTIN, Calif., Oct. 28 P... clinical stage biopharmaceutical,company developi...er and,serious virus infections, today announced t...stor Forum 2008 on Thursday, October 30, 2008 at,3...eld at the Palace Hotel,in San Francisco., A live...
...patients with symptomatic Chronic,Obstructive Pulm...ta show reductions in moderate and severe exacerba...on for marketing authorisation in EU and US expect...ation in the US to be initiated, ZURICH, Switzerl...results from a preliminary analysis of four Phase ...
Other Biology Technology:SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 2SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 3Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 2Nycomed's Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies 2Nycomed's Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies 3...urce: Calf thymus Description: Topoisomerase I r...DNA by a transient breakage and rejoining of phosp...ith Topoisomerase I allows molecules to be differe...phoresis (3) . Topoisomerase I is active in the ab...
...A Polymerase I catalyzes the template-directed pol...3 direction. DNA Polymerase I possesses a 3?5 exon... lowers the error rate during DNA replication, and...nables the enzyme to replace nucleotides in the gr...
T7 RNA Polymerase from Invitrogen
T7 RNA Polymerase from Roche Applied Science
Biology Products: